Table 3.
Meta-analysis of studies reporting discriminatory performance of additive and logistic EuroSCORE in CABG and OPCAB
| Patients | Events | Mortality % (SE) | AUC | 95% CIs (SE) | |
|---|---|---|---|---|---|
| CABG | |||||
| Antunes et al.19 | 4567 | 44 | 0.96 (0.33) | 0.754 | 0.68–0.83 (0.04) |
| Asimakopoulos et al.21 | 4654 | 152 | 3.27 (0.26) | 0.76 | 0.72–0.80 (0.02) |
| Biancari et al.23 | 1098 | 5 | 0.46 (0.26) | 0.856 | 0.67–1.00 (0.09) |
| Farrokhyar et al.26 | 1693 | 26 | 1.54 (0.41) | 0.81 | 0.71–0.90 (0.05) |
| Parolari (current study) | 3440 | 29 | 0.84 (0.42) | 0.813 | 0.73–0.90 (0.04) |
| Toumpoulis et al.31 | 3760 | 103 | 2.74 (0.47) | 0.75 | 0.71–0.80 (0.02) |
| Total | 19 212 | 359 | 1.87 (0.098) | 0.767 | 0.742–0.792 (0.13) |
| OPCAB | |||||
| Al-Ruzzeh et al.20 | 1907 | 26 | 1.36 (0.27) | 0.75 | 0.64–0.85 (0.05) |
| Farrokhyar et al.26 | 1657 | 30 | 1.81 (0.33) | 0.79 | 0.71–0.88 (0.04) |
| Parolari (current study) | 1140 | 9 | 0.79 (0.26) | 0.773 | 0.63–0.91 (0.07) |
| Youn et al.32 | 757 | 10 | 1.32 (0.41) | 0.71 | 0.55–0.87 (0.08) |
| Total | 5461 | 75 | 1.37 (0.16) | 0.766 | 0.709–0.823 (0.029) |
Estimate for delta AUC (CABG–OPCAB)=0.001 (95% CI −0.061 to 0.063, SE 0.032).